These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34109109)
41. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Miller GJ; Stapleton GE; Hedlund TE; Moffat KA Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072 [TBL] [Abstract][Full Text] [Related]
42. UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in the human keratinocyte line HaCaT. Lehmann B; Knuschke P; Meurer M Photochem Photobiol; 2000 Dec; 72(6):803-9. PubMed ID: 11140269 [TBL] [Abstract][Full Text] [Related]
43. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells. Golovko O; Nazarova N; Tuohimaa P Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673 [TBL] [Abstract][Full Text] [Related]
44. Commentary on "randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and Ki67 labeling in prostate cancer patients." Wagner D, Trudel D, Van der Kwast T, Nonn L, Giangreco AA, Li D, Dias A, Cardoza M, Laszlo S, Hersey K, Klotz L, Finelli A, Fleshner N, Vieth R, Department of Nutritional Sciences, University of Toronto, Ontario, Canada.: J Clin Endocrinol Metab 2013;98(4):1498-507 [Epub 2013 Mar 5]. Olumi AF Urol Oncol; 2014 Feb; 32(2):210. PubMed ID: 24445291 [TBL] [Abstract][Full Text] [Related]
45. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Zhuang SH; Burnstein KL Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054 [TBL] [Abstract][Full Text] [Related]
46. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Bemiss CJ; Mahon BD; Henry A; Weaver V; Cantorna MT Arch Biochem Biophys; 2002 Jun; 402(2):249-54. PubMed ID: 12051670 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Nonn L; Peng L; Feldman D; Peehl DM Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780 [TBL] [Abstract][Full Text] [Related]
48. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259 [TBL] [Abstract][Full Text] [Related]
49. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes. Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218 [TBL] [Abstract][Full Text] [Related]
50. An efficient synthesis of 1α,25-dihydroxyvitamin D Kattner L; Bernardi D J Steroid Biochem Mol Biol; 2017 Oct; 173():89-92. PubMed ID: 28179210 [TBL] [Abstract][Full Text] [Related]
51. Effects of 1alpha, 25-dihydroxyvitamin D Kim TH; Park J; Lee JS; Lee HH J Obstet Gynaecol; 2017 May; 37(4):503-509. PubMed ID: 28421904 [TBL] [Abstract][Full Text] [Related]
53. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation. Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412 [TBL] [Abstract][Full Text] [Related]
54. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Zhuang SH; Schwartz GG; Cameron D; Burnstein KL Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366 [TBL] [Abstract][Full Text] [Related]
55. 1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation. Chen WC; Vayuvegula B; Gupta S Clin Exp Immunol; 1987 Sep; 69(3):639-46. PubMed ID: 3117462 [TBL] [Abstract][Full Text] [Related]
56. Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation. Krause R; Roth HJ; Kaase H; Stange R; Holick MF Anticancer Res; 2016 Mar; 36(3):1397-401. PubMed ID: 26977042 [TBL] [Abstract][Full Text] [Related]
57. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Harant H; Andrew PJ; Reddy GS; Foglar E; Lindley IJ Eur J Biochem; 1997 Nov; 250(1):63-71. PubMed ID: 9431991 [TBL] [Abstract][Full Text] [Related]
58. Androgen enhances the antiproliferative activity of vitamin D3 by suppressing 24-hydroxylase expression in LNCaP cells. Lou YR; Tuohimaa P J Steroid Biochem Mol Biol; 2006 Apr; 99(1):44-9. PubMed ID: 16524720 [TBL] [Abstract][Full Text] [Related]
59. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. Jiang F; Li P; Fornace AJ; Nicosia SV; Bai W J Biol Chem; 2003 Nov; 278(48):48030-40. PubMed ID: 14506229 [TBL] [Abstract][Full Text] [Related]
60. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells. Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]